{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T16:02:41Z","timestamp":1768147361240,"version":"3.49.0"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1431,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1365-2559.2011.03941.x","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T11:53:45Z","timestamp":1319198025000},"page":"631-642","source":"Crossref","is-referenced-by-count":28,"title":["Abnormal expression of Nek2 and \u03b2-catenin in breast carcinoma: clinicopathological correlations"],"prefix":"10.1111","volume":"59","author":[{"given":"Shuling","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhua","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tieju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,20]]},"reference":[{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"26431","DOI":"10.1074\/jbc.M704969200","article-title":"Alternative splicing controls nuclear translocation of the cell cycle-regulated Nek2 kinase","volume":"282","author":"Wu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1101\/gad.1596308","article-title":"Beta-Catenin is a Nek2 substrate involved in centrosome separation","volume":"22","author":"Bahmanyar","year":"2008","journal-title":"Genes Dev."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1038\/sj.onc.1210217","article-title":"A novel role of phospho-beta-catenin in microtubule regrowth at centrosome","volume":"26","author":"Huang","year":"2007","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/jcb.21003","article-title":"Centrosome function in normal and tumor cells","volume":"99","author":"Sankaran","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature08136","article-title":"A mechanism linking extra centrosomes to chromosomal instability","volume":"460","author":"Ganem","year":"2009","journal-title":"Nature"},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1349-7006.2008.01075.x","article-title":"Increased expression of centrosomal alpha, gamma-tubulin in atypical ductal hyperplasia and carcinoma of the breast","volume":"100","author":"Niu","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB7|cit7","volume-title":"World Health Organization Classi\ufb01cation of Tumors","author":"Tavassoli","year":"2003"},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0344-0338(11)81095-2","article-title":"Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS)","volume":"189","author":"Remmele","year":"1993","journal-title":"Pathol. Res. Pract."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","article-title":"Breast cancer molecular subtypes respond differently to preoperative chemotherapy","volume":"11","author":"Rouzier","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1158\/1078-0432.CCR-08-2132","article-title":"Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes","volume":"15","author":"Rakha","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/1087057110376537","article-title":"Identification by high-throughput screening of viridin analogs as biochemical and cell-based inhibitors of the cell cycle-regulated Nek2 kinase","volume":"15","author":"Hayward","year":"2010","journal-title":"J. Biomol. Screen."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1038\/sj.onc.1205711","article-title":"The Nek2 protein kinase: a novel regulator of centrosome structure","volume":"21","author":"Fry","year":"2002","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1667\/RR3211","article-title":"Inhibition of centrosome separation after DNA damage: a role for Nek2","volume":"162","author":"Fletcher","year":"2004","journal-title":"Radiat. Res."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1158\/0008-5472.CAN-04-0960","article-title":"The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer","volume":"64","author":"Hayward","year":"2004","journal-title":"Cancer Res."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2005.06.017","article-title":"Nek2 kinase in chromosome instability and cancer","volume":"237","author":"Hayward","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1074\/jbc.M609721200","article-title":"Structure and regulation of the human Nek2 centrosomal kinase","volume":"282","author":"Rellos","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yexmp.2009.12.004","article-title":"Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: a mechanism for aneuploidy in cancer","volume":"88","author":"Liu","year":"2010","journal-title":"Exp. Mol. Pathol."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1349-7006.2008.01007.x","article-title":"Nek2 as a novel molecular target for the treatment of breast carcinoma","volume":"100","author":"Tsunoda","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.1073096","article-title":"Cancer. Addiction to oncogenes-the Achilles heal of cancer","volume":"297","author":"Weinstein","year":"2002","journal-title":"Science"},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jmb.2008.12.033","article-title":"Insights into the conformational variability and regulation of human Nek2 kinase","volume":"386","author":"Westwood","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.1094291","article-title":"Convergence of Wnt, beta-catenin, and cadherin pathways","volume":"303","author":"Nelson","year":"2004","journal-title":"Science"},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1242\/jcs.115.13.2771","article-title":"Regulation of S33\/S37 phosphorylated beta-catenin in normal and transformed cells","volume":"115","author":"Sadot","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ncb1001-913","article-title":"Dynein binds to beta-catenin and may tether microtubules at adherens junctions","volume":"3","author":"Ligon","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/embor.2010.23","article-title":"Conductin\/axin2 and Wnt signalling regulates centrosome cohesion","volume":"11","author":"Hadjihannas","year":"2010","journal-title":"EMBO Rep."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ydbio.2010.05.013","article-title":"Macho-1 regulates unequal cell divisions independently of its function as a muscle determinant","volume":"344","author":"Kumano","year":"2010","journal-title":"Dev. Biol."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB28|cit28","first-page":"80","article-title":"Stem cell therapy for hereditary breast cancer","volume":"43","author":"Rassi","year":"2009","journal-title":"Tsitol. Genet."},{"key":"10.1111\/j.1365-2559.2011.03941.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2559.2011.03941.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2559.2011.03941.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,12]],"date-time":"2021-12-12T04:14:41Z","timestamp":1639282481000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2559.2011.03941.x"}},"subtitle":["Abnormal expression of Nek2 and \u03b2-catenin in breast carcinoma"],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2559.2011.03941.x","relation":{},"ISSN":["0309-0167"],"issn-type":[{"value":"0309-0167","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}